Summary

• The company cannot recommend any practices, procedures, or usage of ICOTYDE that deviate from the approved labeling.
• Please refer to the local labeling for relevant information regarding vaccinations with ICOTYDE.

COMPANY CORE DATA SHEET

Warnings and Precautions

Immunizations

• Prior to initiating therapy with ICOTYDE, consider completion of all age-appropriate immunizations according to current immunization guidelines.¹ 
• No data are available on the response to live or inactive vaccines.¹ 
• Avoid use of live vaccines in patients during treatment with ICOTYDE. Live vaccines may be administered 3 days after discontinuation of ICOTYDE.¹

Literature Search

A literature search of MEDLINE^®, EMBASE^®, BIOSIS Previews^®, and DERWENT^® (and/or other resources, including internal/external databases) was conducted on 5 February 2026.